Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 675

1.

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sánchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective International Survey and HPV Time Trends Study Group.

Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8. Epub 2010 Oct 15.

PMID:
20952254
2.

Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, Snyman L, Wiredu E, Molijn A, Quint W, Ramakrishnan G, Schmidt J.

Int J Cancer. 2014 Mar 15;134(6):1389-98. doi: 10.1002/ijc.28425. Epub 2013 Nov 14.

3.

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.

Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE.

J Natl Cancer Inst. 2009 Apr 1;101(7):475-87. doi: 10.1093/jnci/djn510. Epub 2009 Mar 24.

4.

Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay.

Berois N, De Cremoux P, Mazal D, Sica A, Cedeira M, Caserta B, Barrios E, Osinaga E, Sastre-Garau X.

Int J Gynecol Cancer. 2013 Mar;23(3):527-32. doi: 10.1097/IGC.0b013e318285e753.

PMID:
23392403
5.

Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.

Iljazović E, Mena M, Tous S, Alemany L, Omeragić F, Sadiković A, Clavero O, Vergara M, Bosch FX, de Sanjosé S.

Cancer Epidemiol. 2014 Oct;38(5):504-10. doi: 10.1016/j.canep.2014.06.004. Epub 2014 Aug 11.

PMID:
25130915
6.

Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.

Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Groupa.

Int J Gynecol Cancer. 2013 Mar;23(3):500-6. doi: 10.1097/IGC.0b013e318280f26e.

PMID:
23392401
7.

Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.

Bao YP, Li N, Smith JS, Qiao YL.

Int J STD AIDS. 2008 Feb;19(2):106-11. doi: 10.1258/ijsa.2007.007113.

PMID:
18334063
8.

HPV genotypes: implications for worldwide cervical cancer screening and vaccination.

Wheeler CM.

Lancet Oncol. 2010 Nov;11(11):1013-4. doi: 10.1016/S1470-2045(10)70249-7. Epub 2010 Oct 15. No abstract available.

PMID:
20952255
9.

Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.

Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, Benevolo M, Quirós B, Lloveras B, Klaustermeier JE, Quint W, de Sanjosé S, Bosch FX.

BMC Cancer. 2010 Jun 4;10:259. doi: 10.1186/1471-2407-10-259.

10.

The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Int J Gynecol Cancer. 2001 Jan-Feb;11(1):39-48.

PMID:
11285032
11.

Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases.

Kasamatsu E, Cubilla AL, Alemany L, Chaux A, Tous S, Mendoza L, Paez M, Klaustermeier JE, Quint W, Lloveras B, de Sanjose S, Muñoz N, Bosch FX.

J Med Virol. 2012 Oct;84(10):1628-35. doi: 10.1002/jmv.23373.

PMID:
22930512
12.

Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.

Pilch H, Günzel S, Schäffer U, Tanner B, Brockerhoff P, Maeurer M, Höckel M, Hommel G, Knapstein PG.

Zentralbl Gynakol. 2001 Feb;123(2):91-101.

PMID:
11265139
13.

Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues.

Huang LW, Chao SL, Chen PH, Chou HP.

J Clin Virol. 2004 Apr;29(4):271-6.

PMID:
15018855
14.

Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.

Serrano B, de Sanjosé S, Tous S, Quiros B, Muñoz N, Bosch X, Alemany L.

Eur J Cancer. 2015 Sep;51(13):1732-41. doi: 10.1016/j.ejca.2015.06.001. Epub 2015 Jun 26.

PMID:
26121913
15.

HPV genotyping in cervical cancer in Northern Thailand: adapting the linear array HPV assay for use on paraffin-embedded tissue.

Siriaunkgul S, Suwiwat S, Settakorn J, Khunamornpong S, Tungsinmunkong K, Boonthum A, Chaisuksunt V, Lekawanvijit S, Srisomboon J, Thorner PS.

Gynecol Oncol. 2008 Mar;108(3):555-60. doi: 10.1016/j.ygyno.2007.11.016. Epub 2008 Jan 15.

PMID:
18199473
16.

Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia.

Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K.

Gynecol Oncol. 2011 Jun 1;121(3):522-6. doi: 10.1016/j.ygyno.2011.01.033. Epub 2011 Feb 24.

PMID:
21353296
17.

Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.

Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.

J Med Virol. 2011 Jun;83(6):1034-41. doi: 10.1002/jmv.22081.

PMID:
21503917
18.

Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS, Snijders PJ, Meijer CJ, Bosch FX; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group.

J Natl Cancer Inst. 2006 Mar 1;98(5):303-15.

PMID:
16507827
19.

Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention.

Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andújar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Muñoz N, Bosch FX, de Sanjosé S; Spanish study group RIS HPV TT.

Gynecol Oncol. 2012 Mar;124(3):512-7. doi: 10.1016/j.ygyno.2011.11.024. Epub 2011 Nov 23.

PMID:
22119990
20.

Distribution of human papillomavirus genotypes in archival cervical tissue from women with cervical cancer in urban Sri Lanka.

Samarawickrema NA, Tabrizi SN, Hewavisenthi J, Leong T, Garland SM.

Int J Gynaecol Obstet. 2011 Nov;115(2):180-2. doi: 10.1016/j.ijgo.2011.05.021. Epub 2011 Aug 27.

PMID:
21872246

Supplemental Content

Support Center